These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1057 related articles for article (PubMed ID: 32244180)

  • 1. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity.
    Zeng X; Xie YJ; Liu YT; Long SL; Mo ZC
    Clin Chim Acta; 2020 Mar; 502():214-221. PubMed ID: 31733195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Androgens and polycystic ovary syndrome.
    Nisenblat V; Norman RJ
    Curr Opin Endocrinol Diabetes Obes; 2009 Jun; 16(3):224-31. PubMed ID: 19390322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review on inositol's potential in cyclic disturbances of adipose-endocrinology-associated polycystic ovary syndrome.
    Almalki WH
    Mol Cell Biochem; 2021 Aug; 476(8):2943-2949. PubMed ID: 33755878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic Ovary Syndrome.
    Azziz R
    Obstet Gynecol; 2018 Aug; 132(2):321-336. PubMed ID: 29995717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Diagnostics of polycystic ovary syndrome].
    Lazúrová I; Figurová J; Lazúrová Z
    Vnitr Lek; 2015 Dec; 61(12 Suppl 5):5S40-4. PubMed ID: 27124971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
    Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
    Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen excess and metabolic disorders in women with PCOS: beyond the body mass index.
    Condorelli RA; Calogero AE; Di Mauro M; Mongioi' LM; Cannarella R; Rosta G; La Vignera S
    J Endocrinol Invest; 2018 Apr; 41(4):383-388. PubMed ID: 28942551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polycystic ovary syndrome in the pediatric population.
    Bremer AA
    Metab Syndr Relat Disord; 2010 Oct; 8(5):375-94. PubMed ID: 20939704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications.
    Diamanti-Kandarakis E
    Expert Rev Mol Med; 2008 Jan; 10():e3. PubMed ID: 18230193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nutrient-Induced Inflammation in Polycystic Ovary Syndrome: Role in the Development of Metabolic Aberration and Ovarian Dysfunction.
    González F
    Semin Reprod Med; 2015 Jul; 33(4):276-86. PubMed ID: 26132932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Source and amount of carbohydrate in the diet and inflammation in women with polycystic ovary syndrome.
    Barrea L; Marzullo P; Muscogiuri G; Di Somma C; Scacchi M; Orio F; Aimaretti G; Colao A; Savastano S
    Nutr Res Rev; 2018 Dec; 31(2):291-301. PubMed ID: 30033891
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polycystic ovary syndrome as a plausible evolutionary outcome of metabolic adaptation.
    Dumesic DA; Padmanabhan V; Chazenbalk GD; Abbott DH
    Reprod Biol Endocrinol; 2022 Jan; 20(1):12. PubMed ID: 35012577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bariatric Surgery Improves Hyperandrogenism, Menstrual Irregularities, and Metabolic Dysfunction Among Women with Polycystic Ovary Syndrome (PCOS).
    Christ JP; Falcone T
    Obes Surg; 2018 Aug; 28(8):2171-2177. PubMed ID: 29500679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment.
    Escobar-Morreale HF
    Nat Rev Endocrinol; 2018 May; 14(5):270-284. PubMed ID: 29569621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of obesity on reproduction in women with polycystic ovary syndrome.
    Pasquali R; Gambineri A; Pagotto U
    BJOG; 2006 Oct; 113(10):1148-59. PubMed ID: 16827825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
    O'Reilly MW; Kempegowda P; Jenkinson C; Taylor AE; Quanson JL; Storbeck KH; Arlt W
    J Clin Endocrinol Metab; 2017 Mar; 102(3):840-848. PubMed ID: 27901631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recommendations for epidemiologic and phenotypic research in polycystic ovary syndrome: an androgen excess and PCOS society resource.
    Azziz R; Kintziger K; Li R; Laven J; Morin-Papunen L; Merkin SS; Teede H; Yildiz BO
    Hum Reprod; 2019 Nov; 34(11):2254-2265. PubMed ID: 31751476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prevalence of metabolic disorders in various phenotypes of polycystic ovary syndrome: a community based study in Southwest of Iran.
    Tehrani FR; Rashidi H; Khomami MB; Tohidi M; Azizi F
    Reprod Biol Endocrinol; 2014 Sep; 12():89. PubMed ID: 25224635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 53.